Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.760
+0.030 (1.10%)
At close: Apr 2, 2025, 4:00 PM
2.910
+0.150 (5.43%)
After-hours: Apr 2, 2025, 4:32 PM EDT

Anixa Biosciences Cash Flow Statement

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jan '25 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20 2015 - 2019
Net Income
-12.48-12.55-9.81-13.6-12.95-10.02
Upgrade
Depreciation & Amortization
0.030.040.050.040.060.09
Upgrade
Loss (Gain) From Sale of Assets
-----0.010.15
Upgrade
Stock-Based Compensation
4.64.84.746.758.064.14
Upgrade
Other Operating Activities
-0.39-0.14-0.12-0.18-0.17-0.07
Upgrade
Change in Accounts Receivable
0.390.1-0.22-0.03-0.06
Upgrade
Change in Accounts Payable
0.240.32-0.060.13-0.1-0.35
Upgrade
Change in Other Net Operating Assets
-0.310.11-0.780.390.17-0.17
Upgrade
Operating Cash Flow
-7.93-7.34-6.21-6.49-4.94-6.18
Upgrade
Capital Expenditures
------0.02
Upgrade
Sale of Property, Plant & Equipment
----0.04-
Upgrade
Investment in Securities
6.854.28-5.6-10.73-3.96-0.29
Upgrade
Investing Cash Flow
6.854.28-5.6-10.73-3.92-0.31
Upgrade
Issuance of Common Stock
3.353.420.370.4531.579.41
Upgrade
Repurchase of Common Stock
-0.01-0.01----
Upgrade
Other Financing Activities
-2.21-----
Upgrade
Financing Cash Flow
1.143.420.370.4531.579.41
Upgrade
Net Cash Flow
0.060.36-11.45-16.7722.712.93
Upgrade
Free Cash Flow
-7.93-7.34-6.21-6.49-4.94-6.19
Upgrade
Free Cash Flow Margin
---2956.67%--964.45%-
Upgrade
Free Cash Flow Per Share
-0.25-0.23-0.20-0.21-0.17-0.28
Upgrade
Levered Free Cash Flow
-3.29-3-3.02-1.260.04-2.64
Upgrade
Unlevered Free Cash Flow
-3.29-3-3.02-1.260.04-2.64
Upgrade
Change in Net Working Capital
-0.35-0.571.01-0.52-0.130.41
Upgrade
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q